PPTA Twitter

PlasmaProteins “IVIG has not only saved my quality of life, it has given me a reason to keep trying." – Dave, living with CIDP. Read more of his story at bit.ly/2Q3nnIW #GBSCIDPAwareness
About 21 hours ago.
PlasmaProteins Thank you @Asm_Nazarian for authoring #AB2199 which will increase California #plasma donation, create jobs, help patients @CoalitionHemoB @gbscipd and could lead to therapies for #COVID19 . @ASM_Irwin bit.ly/COVID-19Resource pic.twitter.com/QumaZGSGDJ
11 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100